|
ردیف
|
عنوان
|
ارائه دهنده
|
تاریخ
|
تک برگ خلاصه مقاله
|
|
1
|
Management
of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the
2020 Updated U.S. Department of Veterans Affairs and U.S. Department of
Defense Clinical Practice Guideline
|
دکتر زراعتکار
|
1400/01/26
|
click
|
|
2
|
The effects of
opium on the cardiovascular system: a review of side effects, uses, and
potential mechanisms
|
دکتر تورجی
|
1400/02/09
|
click
|
|
3
|
Association of
Statin Use With Disability-Free Survival and Cardiovascular Disease Among
Healthy Older Adults
Evaluation
of Time to Benefit of Statins for the Primary Prevention of Cardiovascular
Events in Adults Aged 50 to 75 Years A Meta-analy
|
دکتر اخوان
دکتر حاجیان
|
1400/02/30
|
click
|
|
4
|
The antiphospholipid syndrome
– often overlooked cause of vascular occlusions?
|
دکتر نصرتی
دکتر سیاه مشته
|
1400/03/13
|
click
|
|
5
|
Use of
direct oral anticoagulants in patients with thrombotic antiphospholipid
syndrome: Guidance from the Scientific and Standardization Committee of the
International Society on Thrombosis and Haemostasis
|
دکتر رفعتی
|
1400/03/27
|
click
|
|
6
|
Glycated Hemoglobin
and Subclinical Atherosclerosis in People Without Diabetes
|
دکتر خداپرست
|
1400/04/10
|
click
|
|
7
|
Glucose-Lowering
Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
|
دکتر دریایی
|
1400/04/17
|
click
|
|
8
|
Early
Rhythm-Control Therapy in Patients with Atrial Fibrillation
|
دکتر تورجی
|
1400/04/24
|
click
|
|
9
|
Ultraslow
thrombolytic therapy: A novel strategy in the management of PROsthetic
MEchanical valve Thrombosis and the predictors of outcomE: The Ultra-slow
PROMETEE trial
Comparison
of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis
|
دکتر عباسی
دکتر شهسوارپور
|
1400/05/14
|
click
|
|
10
|
The 2018
European Heart Rhythm Association Practical Guide on the use of non-vitamin K
antagonist oral anticoagulants in patients with atrial fibrillation (17.
Atrial fibrillation patients presenting with acute stroke while on
non-vitamin K antagonist oral Anticoagulants)
|
دکتر رفعتی
|
1400/05/21
|
click
|
|
11
|
Features,
Evaluation, and Treatment of Coronavirus
Neutralizing
monoclonal antibodies for treatment of COVID-19
|
دکتر ثقفی
دکتر رعنایی
|
1400/06/11
|
click
|
|
12
|
Clinical
effectiveness of primary prevention implantable cardioverter-defibrillators:
results of the EU-CERT-ICD controlled multicentre cohort study
|
دکتر رفعتی
|
1400/06/18
|
click
|
|
13
|
Patient-tailored
antithrombotic therapy following percutaneous coronary intervention
|
دکتر تورجی
|
1400/06/24
|
click
|
|
14
|
Patient-tailored
antithrombotic therapy following percutaneous coronary intervention
|
دکتر تورجی
|
1400/07/01
|
click
|
|
15
|
Trial of Intensive Blood-Pressure Control in Older Patients with
Hypertension
|
|
1400/07/22
|
click
|
|
16
|
مقایسه اثرات درمان
محافظتی در مقابل درمان تهاجمی در بیماران CAD
پایدار
|
|
1400/08/05
|
click
|
|
17
|
P Wave Indices-Advancing
Our Understanding of Atrial Fibrillation-Related Cardiovascular Outcomes
|
دکتر اخوان
|
1400/08/13
|
click
|
|
18
|
Implantable loop
recorder detection of atrial fibrillation to prevent stroke (The LOOP Study):
a randomised controlled trial
|
دکتر رحمانی
|
1400/09/03
|
click
|
|
19
|
Effect of
Empagliflozin on Worsening Heart
Failure Events in Patients With Heart Failure and
Preserved Ejection Fraction
|
دکترمعزی- دکتر اکبری
|
1400/10/09
|
click
|
|
20
|
6سوال بالینی مطرح شده:
1-جایگزینیR+PA به جای Altplدرترومبوز دریچه
2-بررسی STEدرلیدAVRدربیمارانACS
3-مطالعه دروس
علوم پزشکی به زبان Non nativeیا Nativeدر دانشجویان پزشکی
4-درمان با Coronarysyn post acute Atorvast vs high intensity Ropix
5-تاثیر Physical activity Exercise برروی کیفیت زندگی
بیماران
6-تاثیر Depression And Anxiety در pre mature CAD
|
Pico-cat
|
14/11/1400
|
click
|
|
21
|
1-Cordovez RA. Association of aVR
ST-elevation with outcomes in patients with acute coronary syndrome.
2- Wang A ,et al.Prognostic implications of ST-segment
elevation in lead aVR in patients with acute coronary syndrome: A
meta-analysis.
3-- Adem Adar et al. Relationship between ST-Segment Shifts in Lead aVR
and Coronary Complexity in Patients with Acute Coronary Syndrome.
4--Jennifer J. Et al,aVR
ST Segment Elevation: Acute STEMI or Not? Incidence of an Acute Coronary
Occlusion,
.5- Ko W, Hurng
G, Zhou R, et al. A Systematic Approach to Evaluate Patients Presenting With
ST-Segment Elevation in Lead aVR: A Case Series.
6- Hiltner E ,et al. Is
isolated ST segment elevation in Lead aVR associated with high grade coronary
artery disease?
|
Pico-cat
|
21/11/1400
|
click
|
|
22
|
Segment Elevation: Acute STEMI or Not? Incidence of an Acute
Coronary Occlusion,
|
Pico-cat
|
28/11/1400
|
click
|